Rachel Ochs-Ross, MD, a director at Janssen Research & Development in Titusville, New Jersey, and colleagues led a phase 3 double-blind randomized active-controlled multicenter trial of older adults.
We surveyed HCPs about CBD to find out if and how the phytocannabinoid is affecting practices across America.
The efficacy of melatonin, which has shown a prophylactic antidepressant effect in breast cancer, was explored given the prevalence of depressive symptoms after ACS.
Patients with moderate depression, anxiety, stress symptoms more likely to drop out of rehab.
Most trials assess short-term effects, whereas more than 60% of people in the United States on antidepressants have taken them for more than 2 years.
Researchers assessed the impact of a 30- or 90-minute nap on individuals with major depressive disorder.
No association seen between oral contraceptives, depressive symptoms when ages 16 to 25 years were combined.
The tolerability and novel mechanism of action of SAGE-217, an oral positive allosteric modulator of γ-aminobutyric acid type A receptors, might make it a valuable addition to the antidepressant armamentarium.
Children with asthma and anxiety, depression, or both have increased rates of asthma-linked ED use.
Lithium use was associated with lower intensity of depressive symptoms, reduced clinical severity, and lower benzodiazepine use.
